TG Therapeutics Inc logo

TG Therapeutics Inc

FRA:NKB2 (USA)   Ordinary Shares
€ 30.29 (+0.68%) Jan 3
At Loss
P/B:
25.34
Market Cap:
€ 4.67B ($ 4.81B)
Enterprise V:
€ 4.59B ($ 4.73B)
Volume:
835.00
Avg Vol (2M):
1.01K
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

AAPL Stock Intrinsic Values - Apple Inc